Valid Ghana · FDA Ghana

RIFAPENTINE+ISONIAZID TABLETS 300mg/300mg

Rifapentine_Isoniazid

FDA/GD.253-020036 Rifapentine_Isoniazid 300mg/300mg

What it does

Rifapentine and isoniazid are antibiotics used together to treat tuberculosis (TB).

Commonly used for: tuberculosis (TB), active tuberculosis infection

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/GD.253-020036
Registration date
2025-02-24
Expiry date
2028-03-01
Status
Valid
Active ingredient
Rifapentine_Isoniazid
Dosage form
Rifapentine_Isoniazid
Strength
300mg/300mg
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Lupin
Applicant / LTR
Supra Pharma Ltd, - No.6 NII Bonie Loop Dzorwulu Accra, Ghana.
Country of origin
-
Manufacturer location
MIDC Industrial Area, Chilkalthana, Chhatrapati Sambhajinagar, Maharashtra 431006, India

Source: Food and Drugs Authority · fetched 2026-04-18 08:37:17 · updated 2026-10-20 04:00:09

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Rifapentine and isoniazid are antibiotics used together to treat tuberculosis (TB).

What it treats

  • tuberculosis (TB)
  • active tuberculosis infection

How it works

These medications work by killing the bacteria that cause tuberculosis and preventing them from growing.

Who it's for

This treatment is for people diagnosed with active tuberculosis.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.